发明名称 GI-ENDOCRINE DRUG DELIVERY DEVICE AND METHOD OF USE
摘要 Shown are a device, system and method that improve the diabetes care of a patient that has undergone gastric surgery. The device provides continuously or intermediate monitoring at various intervals before and after meals of several sensors to perceive, among other things, the blood glucose level, EKG/heart rate and volume of meals a patient has consumed. Readings are sent to a control unit that receives input from at least one of: a meal sensor, glucose monitor, and EKG sensor to control a drug delivery unit that doses a prescribed agent at a specific quantity and time based on the readings to provide proper diabetes care for the patient. Components of the system such as the meal sensor glucose monitor, EKG sensor, control unit and drug delivery device may be implanted subcutaneously in the patient or outside the patient and may communicate with each other either wirelessly or may be directly wired together.
申请公布号 US2017007434(A1) 申请公布日期 2017.01.12
申请号 US201615206886 申请日期 2016.07.11
申请人 Hamilton Scientific, Ltd. 发明人 Rothkopf Michael
分类号 A61F5/00;A61M5/172;A61M5/142 主分类号 A61F5/00
代理机构 代理人
主权项 1. A gastric drug delivery device for improving diabetes patient care, comprising: a meal sensor apparatus having a base; the base defining a chamber; a pressure transducer disposed within the meal sensor apparatus, and the pressure transducer in fluid communication with the chamber; a gastric band bladder in fluid communication with the chamber, and wherein deflection of the band bladder causes a pressure differential in the chamber that is readable by the transducer.
地址 Roseland NJ US